Clinical trial / 2013
A 13C-tracer study in 8 men showed that cyanidin-3-glucoside had a relative bioavailability of 12.38% and metabolites persisted in circulation for up to 48 hours.
Eight male participants ingested 500 mg of 13C-labeled cyanidin-3-glucoside, and biological samples were analyzed over 48 hours. Total 13C recovered in urine, breath, and feces was 43.9 ± 25.9% (range: 15.1-99.3%), with a relative bioavailability of 12.38 ± 1.38% (5.37 ± 0.67% in urine and 6.91 ± 1.59% in breath). Serum 13C-labeled metabolites peaked at 10.25 ± 4.14 h (maximum concentration: 5.97 ± 2.14 μmol/L), with half-lives ranging from 12.44 ± 4.22 to 51.62 ± 22.55 h. Metabolites included degradation products, phenolic, hippuric, phenylacetic, and phenylpropenoic acids.
- Study type
- Isotope-tracer metabolic study
- Who was studied
- 8 male participants
- What was measured
- Metabolism, elimination, bioavailability, and metabolite concentrations over 48 h
THE PAPER
Human metabolism and elimination of the anthocyanin, cyanidin-3-glucoside: a (13)C-tracer study.
Czank C, Cassidy A, Zhang Q, Morrison DJ, Preston T, Kroon PA, Botting NP, Kay CD. Am J Clin Nutr, 2013.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.